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Abstract
Background: During the process that AIV infect hosts, the NS1 protein can act on hosts, change corresponding
signal pathways, promote the translation of virus proteins and result in virus replication.
Results: In our study, we found that PARP domain and Glu-rich region of PARP10 interacted with NS1, and the
presence of NS1 could induce PARP10 migrate from cytoplasm to nucleus. NS1 high expression could reduce the
endogenous PARP10 expression. Cell cycle analysis showed that with inhibited PARP10 expression, NS1 could
induce cell arrest in G2-M stage, and the percentage of cells in G2-M stage rise from the previous 10%-45%,
consistent with the cell proliferation result. Plague forming unit measurement showed that inhibited PARP10
expression could help virus replication.
Conclusions: In a word, our results showed that NS1 acts on host cells and PARP10 plays a regulating role in virus
replication.
Background
The NS1 protein of avian influenza virus (AIV) is pre-
sent in host cells infected by the virus instead of being
p r e s e n ti nm a t u r ev i r i o n s ,s oi ti sa l s oc a l l e dn o n s t r u c -
tural protein (NS) [1]. The NS1 protein has two nuclear
localization signals, which can induce synthesized NS1
migrate rapidly to nuclei, and aggregate in nuclei early
infected by virus. While in late phase of infection, NS1
aggregates in nucleoli and forms a compact crystal-like
inclusion body [2].
Studies show that amino-terminal RNA binding region
and carboxyl-terminal effector domain of the NS1 pro-
tein are closely related to protein synthesis in host cells
[3,4]. By binding different types of RNA in host cells,
RNA binding region of the NS1 protein can inhibit
polyadenylation and splicing of mRNA in host cells, and
block protein synthesis [5,6]. Effector domain of the
NS1 protein can interact with nuclear protein of host
cells, inhibit nuclear export of mRNA, and be used in
virus mRNA synthesis [7]. In addition, NS1 can bind
dsRNA, inhibit NF-B activation and IFN-b synthesis,
and prevent PKR from activation; NS1 can also inhibit
PKR from activation by directly acting on it, and thus
inhibit cell apoptosis [8] and make virus exempt from
immune reaction in host.
With NS1 of AIV-H5N1 as bait, we screened a protein
interacting with NS1 through yeast two-hybrid experi-
ment, i.e. poly (ADP-ribose) polymerases 10 (PARP10),
a member of PARP family. Studies showed that all 18
members of PARP family have PARP activity and can
modify part of protein in nuclei [9]. Studies also found
that the protein family plays certain regulating role in
DNA replication and repair [10,11], gene transcriptional
regulation [12-14], cell cycle [15], proliferation [16], cell
apoptosis and necrosis [17-19]; moreover, PARP family
members also play certain modification regulating role
in physiological and pathological processes like inflam-
mation [20], tumor [21,22] and aging [23,24].
PARP 10 has many domains. C-terminal PARP
domain can modify itself and core histone through
PARP activity [16]; Leu-rich nuclear export sequence
* Correspondence: amms832@126.com; peitanghuang@yahoo.cn
† Contributed equally
1Institute of Biotechnology, Academy of Military Medical Sciences, Beijing
100071, People’s Republic of China
Full list of author information is available at the end of the article
Yu et al. Virology Journal 2011, 8:546
http://www.virologyj.com/content/8/1/546
© 2011 Yu et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons
Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly cited.can promote itself to localize in cytoplasm, and the
absence of the sequence can induce PARP10 aggregate
in nuclei; 2 C-terminal ubiquitin-binding motifs can reg-
ulate nuclear transport of protein [16]. Further study
showed that PARP10 can inhibit transformation of rat
embryo fibroblasts through interrupting Myc and E1A
pathways with its nuclear export sequence [16]. Study
also found that during late G1 stage to S stage, PARP10
aggregated in nucleoli participates in regulation of cell
proliferation through phosphorylation and binding RNA
polymerase I [25].
Synthesized PARP10 in cytoplasm can migrate to
nuclei, and this provides a space for interaction between
PARP10 and NS1. Therefore, research on their interac-
tion and the physiological function induced can help to
explore how PARP10 affects AIV replication. Our study
results show that the interaction between PARP10 and
NS1 can change cell cycle, and PARP10 can affect virus
replication, which provides some clue for the virus repli-
cation mechanism in cells.
Materials and methods
Cell culture
A549 cells were cultured in McCoy’s5 Am e d i u m .
BHK21, NIH3T3 and MDCK cells were cultured in Dul-
becco’s modification of Eagle’s medium (DMEM). All
media were supplemented with 10% fetal bovine serum
(Hyclone) and cells were maintained at 37°C in a 5%
CO2 atmosphere.
Plasmid construction
c D N Ae n c o d i n go fh u m a nP A R P 1 0a n dN S 1o fH 5 N 1
AIV were cloned into pDsRed-C1 and pEGFP-N3 vectors
respectively for co-localization experiment. Truncated
forms of human PARP10 (as indicated in the figure
legends) were generated by PCR and cloned into pCMV-
Myc, and cDNA of NS1 were cloned into pCMV-Flag for
co-immunoprecipitation. pGEX-6p-1-NS1 was con-
structed to express the GST-NS1 fusion protein. The
DNA sequence corresponding to PARP10 nucleotides
617-635 was subcloned into pEGFP-C1H1U6 vector to
transcribe short hairpin RNA (shRNA).
Antibodies and western blotting
The primary antibodies used were as follows: mouse
monoclonal antibodies Anti-b-actin (Promega), anti-Myc
(Promega), anti-Flag (Promega), and rabbit anti-PARP10
(Bethyle) were obtained by commercially, and polyclonal
antibody anti-M1 was generated by our lab. Horseradish
peroxidase (HRP) labeled secondary antibodies were
purchased from Santa Cruz Biotech. Western blot ana-
lyses of total cell lysate were performed using sodium
dodecyl sulfate polyacrylamide gel electrophoresis (SDS-
PAGE) methods with 10% polyacrylamide gels. After
electrotransfer to polyvinylidene fluoride (PVDF) mem-
branes (Amersham), the interesting proteins were visua-
lized using antibodies as described above.
Verification of the interaction
For in vitro interaction assays, bacterial expressed GST-
NS1 fusion protein was purified through protein purifi-
cation system ÄKTA
KM Purifier. After Myc-PARP10
fusion protein was expressed in A549 cells, whole-cell
lysates were prepared in radioimmunoprecipitation assay
(RIPA) buffer and centrifuged to obtain supernatant.
GST-pulldown was performed as per the instruction of
MagneGST™ Glutathione Particle kit (Promega). The
GST-NS1 and Myc-PARP10 fusion proteins were identi-
fied by Western blotting.
For in vivo interaction assays, A549 cells were trans-
fected with pCMV-Myc-PARP10 and pCMV-Flag-NS1
plasmids for transient expression and whole-cell lysates
were prepared in RIPA buffer. Coimmunoprecipitated
proteins were detected by Western blot analysis. Myc-
PARP10 and Flag-NS1 expression were analysed by
Western blotting using whole-cell extracts prepared in
RIPA buffer. For immunoprecipitations and Western
blot analysis, anti-Flag and anti-Myc antibodies were
used. Co-immunoprecipitation was performed as per the
instruction of Protein A/G plus-Agarose beads kit
(Promega).
Colocalization analysis
A549 cells were maintained in the center of 35 mm
glass Petri dish till 80% confluence, then cotransfected
with plasmids encoding NS1 tagged with green fluores-
cent protein (GFP-NS1) and PARP10 tagged with red
fluorescent protein (RFP-NS1) using Lipofectamine 2000
(Ivitrogen) according to the manufacturer’s instructions.
After 16 h of transfection, cells were rinsed once with
pre-cooled phosphate buffered saline (PBS) and added
4% paraformaldehyde to retain cells at 4°C for 5 min.
Cells were washed twice with pre-cooled PBS and
stained with 500 μl1μmol/L 4’,6-diamidino-2-phenylin-
dole (DAPI) for 5 min at room temperature. At last,
cells were washed three times with PBS, and the co-
localization of target proteins was observed under a
laser co-focal microscope.
Cell cycle measured by flow cytometry
The cells transfected in a 6-well plate were digested with
trypsin, and centrifuged at 1,000 g for 4 min. The sedi-
ment was washed in PBS containing 10% calf serum,
and 70% ethanol in PBS was added to fix the cells at
-20°C for 4 h. The fixed cells were then washed twice
with pre-cooled PBS, incubated for 30 min at 37°C with
1 mg/ml RNaseA solution and stained with 50 μg/ml
propidine iodide (PI) for 10 min away from light. The
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flow cytometry.
Virus proliferation detection
The cells were cultured more than 90% confluence,
rinsed twice with Hanks buffer (Gibico), 1 ml serum-
free medium and 5 × 10
5 pfu H5N1 AIV were added,
and then lightly oscillated to mix up. The plate was
incubated at 37°C for 1 h, and then cells were rinsed
twice with Hanks buffer. 2 ml serum-free medium was
added, and samples were cultured at 37°C. Supernatant
and infected cells were collected at 12, 24, 36, 48, 60
and 72 h respectively, and supplemented to the same
volume with 2 × SDS sample loading buffer. The virus
replication was indirectly identified by Western blotting
with anti-M1 antibody.
TCID50 measurement
BHK21 cells transfected with plasmids were cultured for
24 h, and infected with H5N1 AIV. After virus infection
for 48 h, the plate was placed overnight at -20°C, then
melted, blown and mixed up, and diluted to 10-fold
serial dilution. MDCK cells of more than 90% conflu-
ence in the 96-well plate were washed twice with Hanks
buffer (Gibico), 100 μl serum-free DMEM medium was
added to each well, and seeded 4 wells with diluted
virus sample. At the same time, wells seeded with H5N1
AIV were used as positive control, and serum-free med-
ium was used as negative control. Cells were cultured in
an incubator at 35°C, and the pathological changes were
observed every 24 h till no change was found. The
observation generally lasted 5-7 d. Virus titer was mea-
sured with Reed-Muench method.
Results
NS1 interacts with PARP10
To verify the screening result of yeast two-hybrid sys-
tem, we identified the in vivo and in vitro interaction
between NS1 and PARP10. First, we verified the pre-
sence of the interaction with GST-pull down in vitro. At
low temperature, induced BL21 had soluble expression
of GST-NS1 fusion protein. The protein was about 52
KD, consistent to the size expected. GST and GST-NS1
of high purity were obtained through purification sys-
tem, and mixed with A549 lysate containing Myc-
PARP10 of transient expression, and then used for pull-
down assay. The sediment was examined by Western
blotting using anti-Myc antibody, and the result showed
that GST-NS1 could bind and sediment PARP10, while
GST could not (Figure 1a), indicating that NS1 protein
in vitro could interact with PARP10. Then, we verified
the interaction in vivo between PARP10 and NS1 by co-
immunoprecipitation. Myc-PARP10 was expressed
individually and co-expressed with Flag-NS1 in A549
cells. After transient expression, the cells were lysed
with RIPA lysate, and co-immunoprecipitation was per-
formed. The sediment of co-immunoprecipitation was
identified by Western blotting and the result showed
that NS1 could interact with PARP10 (Figure 1b).
C-terminal of PARP10 interacts with NS1
PARP10 is made up of 1025 amino-acid residues, and it
consists of many domains [16]. To analyze the domains
that PARP10 interacts with NS1, PARP10 cDNA was
divided into four segments according to its encoded
domains (Figure 2a): the first segment was 1503 bp,
encoding similar RNA recognition motif (RRM) and gly-
cine rich region; the second was 1287 bp, encoding gly-
cine rich domain and glutamate rich region; the third
segment was 1281 bp, encoding glutamate rich domain
and PARP domain; and the fourth segment was 1005
bp, encoding PARP domain.
PARP10 was expressed in fragments in A549 cells, and
the C-terminal of PARP10 that interact with NS1 was
identified with co-immunoprecipitation, i.e. catalytic
domain and glutamate rich region of PARP10 (Figure
2b). This also demonstrated that PARP10 and NS1 have
physical interaction.
PARP10 and NS1 can co-localize in nuclei
Localization of PARP10 and NS1 could be directly
observed from cell-level expression of RFP-PARP10 and
GFP-NS1 in A549 cells. Results showed that when
PARP10 fused with red fluorescent protein was transiently
expressed in A549 cells, it was localized in cytoplasm,
while NS1 with green fluorescent label was localized in
nuclei (Figure 3a). If the two proteins were transiently co-
expressed in A549 cells, then the localization of PARP10
would change and mainly aggregate in nuclei, and the red
fluorescent could overlap with green florescent, indicating
that NS1 could change the localization of PARP10 (Figure
3b). The localization result in NIH3T3 cells was same to
that in A549 cells. So the results illustrated that NS1 could
interact with PARP10 and effect PARP10’s location in cells.
NS1 inhibits PARP10 expression
NS1 protein molecules can inhibit protein synthesis and
increase virus protein replication by interrupting normal
mRNA splicing and nuclear export [3-6]. As a kind of
h o s tp r o t e i n ,w a sP A R P 1 0a f f e c t e db yN S 1 ?W em a d e
high expression of NS1 in cells and Western blot analy-
sis showed that endogenous PARP10 expression level
decreased (Figure 4a); RT-PCR assay also found that
NS1 could reduce the transcription of endogenous
PARP10 (Figure 4b). In a word, NS1 can inhibit
PARP10 expression.
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cell cycle
Over expression or lowered expression of PARP10 can
affect cell cycle [25]. We investigated the effect of NS1
and PARP10 on cell cycle by flow cytometry through
regulating NS1 and PARP10 expression level. First,
PARP10 and NS1 expression in each sample were exam-
ined respectively by RT-PCR. Results showed that NS1
and PARP10 expression vector could effectively express
the target proteins, and small interfering RNA (siRNA)
designed for PARP10 coding sequence could effectively
inhibit PARP10 expression (Figure 5a). Flow cytometry
analysis found that with PARP10 expression inhibition,
NS1 could induce cell arrest in G2-M stage. When
PARP10 expression rebounded, the effect of the NS1
protein on cell cycle change disappeared almost (Figure
GST GST-NS1 Input
GST or GST
fusion protein
PARP-10
A
B
-             + Flag-NS1
Myc-PARP-10 +            +
IP:Flag
IB: Myc
Input:
IB: Myc
Input:
IB: Flag
Figure 1 NS1 could have in vitro and in vivo interaction with PARP10. a. Interaction of GST-NS1 and Myc-PARP10 were identified in GST-
pulldown assay. Bacterial expresssed soluble GST and GST-NS1 protein were purified, and SDS-PAGE and Commassie Blue Fast Staining revealed
that GST and GST-NS1 of higher purity were obtained. There was a stripe similar to the size of GST under GST-NS1 stripe, indicating that GST-
NS1 degraded during the purification. Myc-PARP10 was transient expressed in A549 cells and identified by immuno-blotting. The sediment of
GST-pulldown was examined by immno-blotting using anti-Myc antibody. It was found that GST-NS1 could capture Myc-PARP10, while GST
could not. b. NS1 could have in vivo interaction with PARP10. Myc-PARP10 and Flag-NS1 were transiently expressed in A549 cells, which were
lysed in RIPA buffer, co-immunoprecipitated using anti-Myc antibody or anti-Flag antibody, and the sediment obtained was examined by
Western blotting. One tenth of each lysate was taken to identify protein expression.
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Page 4 of 105b), indicating that NS1 and PARP10 expression level
could change the cell cycle of A549.
PARP10 can inhibit the proliferation of H5N1 AIV in cells
The M1 protein is a structural protein of avian influenza
virus and the virus level can be detected indirectly
through Western blotting of the M1 protein. We used
H5N1 AIV to infect A549, COS7 and BHK21 cells,
respectively. The Virus replication magnitude had signif-
icant increase in the supernatant of BHK21 cells 48 h
after the infection, had significant increase in the cells
60 h after the infection, and no significant increase in
the supernatant and in the cells afterwards, indicating
that H5N1 AIV replication reached the peak in BHK21
A
B
+     +      +       +       + Flag-NS1
Myc-PARP-10
Myc-PARP10(aa 1-500)
Myc-PARP10(aa 270-697)
Myc-PARP10(aa 610-1025)
Myc-PARP10(aa 691-1025)
+      - -         -        -
-     +      -         --
-     - +         --
-     - -         +         -
-     - -         -+
IP:Flag
IB: Myc
Input:
IB: Myc
Input:
IB: Flag
Figure 2 NS1 interacting C-terminal of PARP10 identified with co-immunoprecipitation. a. The schematic domain architecture of whole/
truncated PARP10. PARP10 protein was divided into four fragments according to their corresponding domains: RRM domain and glycine rich
region (aa 1-500), glycine rich region and glutamate rich domain (aa 270-697), glutamate rich region and PARP domain (aa610-1025), and PARP
domain (aa 691-1025). Nuclear export signal and two ubiquitin-binding motifs are located at the overlapping area of glutamate rich region and
PARP domain (aa632-697). b. The whole/truncated PARP10 and Flag-NS1 were transiently expressed in A549 cells, which were lysed in RIPA
buffer, co-immunoprecipitated using anti-Myc antibody or anti-Flag antibody, and the sediment obtained was examined by Western blotting.
One tenth of each lysate was taken to identify protein expression.
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Page 5 of 10cells at 48 h (Figure 6). Therefore, we chose BHK21
cells and 48 h after infection to investigate the effect of
PARP10 on AIV proliferation.
PARP10 expression plasmids and PARP10 siRNA
transcription plasmids were transfected into BHK21
cells respectively, with corresponding empty vector as
control, and PARP10 expression in each sample was
detected. It was found that PARP10 expression plasmids
could effectively express PARP10, while PARP10 siRNA
transcription plasmids could effectively inhibit PARP10
expression (Figure 7). Another group of samples trans-
fected at the same time was infected with H5N1 AIV,
and the virus were collected 48 h after the infection to
infect MDCK cells. Plaque forming unit (PFU) of each
virus sample was computed using TCID50 when multi-
plicity of infection (MOI) was diluted to 2, 0.2, 0.02 and
0.002. The data was summarized in Table 1 and 2,
which were one-way ordinal 4 × 2 contingency tables.
The data was analyzed with rank sum test, and the
result showed P = 0.0001 (P < 0.01), indicating the dif-
ference was of statistical significance. In this experiment,
other different MOI could also back this result.
T h er e s u l ts h o w e dt h a tH 5 N 1A I Vm a g n i t u d e
decreased in case of PARP10 transient expression in
BHK21 cells, and H5N1 AIV magnitude grew in case of
PARP10 knock-down in BHK21 cells.
Discussion
We first verified the interaction between NS1 and
PARP10 with co-localization, co-immunoprecipitation
and GST-pull down. Cell co-localization found that the
presence of NS1 could induce the PARP10 protein
A
B
GFP- NS1 DAPI Merge
RFP- PARP-10 DAPI Merge
GFP- NS1 RFP- PARP-10 DAPI Merge
Figure 3 NS1 co-localized with PARP10 in A549 nucleus. a. GFP-NS1 (green) and RFP-RARP10 (red) were transiently expressed respectively in
A549 cells, and nuclei were identified by DAPI (blue) staining. Observation under the microscope showed that GFP-NS1 was mainly localized in
nuclei, while RFP-PARP10 was mainly localized in cytoplasm. b. When the two were co-expressed in A549 cells, RFP-PARP10 migrated from
cytoplasm to nuclei and overlapped with the florescent shed by GFP-NS1, indicating that presence of NS1 could induce localization change of
PARP10.
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Page 6 of 10localized in cytoplasm to migrate from cytoplasm to
nuclei, indicating that NS1 could change localization
and function of PARP10. As PARP10 mainly localized in
nuclei under the action of nuclear export inhibitor, we
supposed that NS1 might inhibit the nuclear export of
PARP10 in nuclei, and make it remain in the nuclei.
Further study found that NS1 acts on Glu-rich region
and PARP domain of PARP10, and Glu-rich region con-
tains potential nuclear export signal and two ubiquitin
interaction motifs (UIM). Some studies report that UIM
play certain regulating role in nuclear export and import
in some proteins [26-28]. The interaction between NS1
and PARP10 might block nuclear export signal (NES)
and UIM of PARP10. As NS1 has two nuclear export
signals, NS1 and PARP10 are co-localized in nuclei
under the action of nuclear export signal of NS1. NS1’s
action on catalytic domain of PARP10 may affect the
enzymatic activity of PARP10. It is reported that NS1
can promote virus replication through interacting with
many proteins of the host and interrupting the normal
expression regulation of host cells. Expression profiles of
human and mouse tissues show that PARP10 is a widely
expressed protein [16], indicating that PARP10 has wide
and fundamental biological functions, and may play cer-
tain role in some basic pathways. Therefore, the interac-
tion between NS1 and PARP10 may involve some basic
biological functions of cells, and also involve some gen-
eral protein molecules in signal transduction and protein
expression regulation.
Individual NS1 protein expression and PARP10 knock-
down did not have significant effect on cell cycle in A549
cells, but the NS1 protein expression and PARP10
knock-down together would significantly induce cell
arrest in G2-M stage, with percentage of cells in G2-M
stage increased from the previous 10%-45%, consistent to
the cell proliferation result. When PARP10 siRNA tran-
scription plasmids, NS1 expression plasmids and PARP10
expression plasmids were co-transfected, it was found
that the percentage of cells in G2-M stage saw significant
decrease, back to the percentage of cells transfected by
empty vector, but the percentage of cells in G1-S stage
grew from less than 10%-20%, indicating that co-transfec-
tion promoted cells progress into S stage. However, there
was a contradictory result that the percentage of cells in
PARP10
ȕ-actin
CK                   NS1  
A
B
CK                   NS1  
PARP10
ȕ-actin
Figure 4 NS1 of high expression in A549 cells could reduce endogenous PARP10 expression. a. NS1 of H5N1 AIV was transiently
expressed in A549 cells, which were then lysed with RIPA buffer, and examined by Western blotting using anti-PARP10 monoclonal antibody,
with b-actin as internal control. It was found that NS1 could reduce PARP10 expression level. b. RT-PCR assay found that with GAPDH as internal
control, PARP10 saw a low RNA expression level because of the high expression of NS1.
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PARP10
pCMV-Myc-PARP10
pEGFP-N3
NS1
GAPDH
A
pCMV-flag-NS1
pEGFP-N3-shRNA
+          -         - - -
-          +         - +          +
-          -          +        +          +
-          -          - -          +
Figure 5 PARP10/NS1 expression level could change cell cycle of A549. a.T o t a lR N Aw a se x t r a c t e df r o mt r a n s f e c t e dc e l l s ,a n dN S 1a n d
PARP10 transcription level were identified by RT-PCR. PARP10 siRNA could significantly reduce PARP10 transcription level; NS1 transient
expression had less inhibition on PARP10, while PARP10 expression vector could effectively express the target proteins. b. Transfect cells was
analyzed by flow cytometry, and it was found that when NS1 transient expression and PARP10 knock-down were performed together, the
percentage of A549 cells in G2-M stage grew to 45% from 10%. When PARP10 expression level was elevated, the percentage of cells in G2-M
stage saw significant decrease, similar to the percentage of cells transfected with empty vector, but the percentage of cells in G1-S stage grew
from less than 10% to 20%.
M3 1   2   3 4
CK    12    24     36     48      60       72     (h)
Cell
ȕ-actin
Supernatant
Figure 6 Proliferative kinetics of AIV H5N1 in BHK21 cells. BHK21 cells were infected directly with H5N1 AIV, and the supernatant and
bottom cells of the sample at 12, 24, 36, 48, 60, 72 h were collected respectively. Finally, samples separated were examined by Western blotting
with anti-M1 antibody respectively, with b-actin as internal control. The result showed that the volume of the M1 protein had significant growth
at 48 h, and less obvious growth afterward.
GAPDH
PARP-10
pCMV-Myc
pCMV-Myc-PARP10
pEGFP-C1H1U6
pEGFP-C1H1U6-shRNA
+             -              -               - 
-             +              -               - 
-             -               +              - 
-             -               -               + 
Figure 7 PARP10 expression level measured with RT-PCR. With GAPDH as internal control, RT-PCR found that PARP10 expression plasmids in
BHK21 cells could effectively express target gene, while PARP10 siRNA transcription plasmids could effectively inhibit target gene expression.
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Page 8 of 10G2-M stage when NS1 protein expression only was not
above the percentage of empty vector, this may be due to
the PARP10 expression level. When PARP10 expression
was inhibited significantly, the cells would be apt to G2-
M stage. When PARP10 expression was inhibited slightly,
the cells would be not apt to G2-M stage. Therefore, this
also indicated that NS1 protein of AIV interacted with
various proteins to change cell cycle and facilitate AIV
infection.
AIV could have quick proliferation in MDCK cells and
induce significant pathological changes, but MDCK cells
have a low transfection rate, and are not suitable for
this study. As AIV is quite selective for hosts, to better
detect PARP10’s effect on virus replication, we explored
the proliferation of H5N1 AIV in A549, BHK21 and
COS7 cells. It was found that the virus replication had
significant growth in BHK21 cells, but slower prolifera-
tion in the other two. As AIV had effective replication
in BHK21 cells and the log growth period of the virus
was between 36 h and 48 h, BHK21 cells were used as
host cells of AIV.
After host cells were decided, we explored the effect of
BHK21 cells on virus proliferation through PARP10 over
expression or knock-down, with 48 h after the infection
as starting point of the detection. The analysis of PFU
showed that PARP10 over expression induced virus
replication decrease, while PARP10 expression inhibition
induced virus replication growth, indicating that AIV
replication is regulated by PARP10 protein molecule,
and PARP10 expression inhibition can promote virus
replication.
In summary, PARP10 can interact with NS1, and the
interaction can affect cell cycle and virus replication.
NS1 might inhibit activity of host cells and promote
virus proliferation through the interaction with PARP10.
The findings provide clue and foundation for virus repli-
cation mechanism in cells.
Conclusions
NS1 of AIV is expressed early in hosts and interacts
with PARP10 to interfere with cell cycle and promote
virus replication. This work is helpful to understand the
mechanism of AIV infection and further work is
required to explore the process of virus replication in
the cells.
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